Hjem › Ikke-småcellet lungekreft › Georgia › Savannah
Kliniske studier for Ikke-småcellet lungekreft i Savannah, GA
10 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Savannah (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi unna
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi unna
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RekruttererFase 3
- Low Country Cancer Care ( Site 0156), Savannah
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
RekruttererFase 3
- Lewis Cancer and Research Pavilion ( Site 0063), Savannah
- Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi unna
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekruttererFase 3
- Research Site, Savannah
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruttererFase 3
- Summit Cancer Care PC, Savannah
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi unna
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi unna
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi unna
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
RekruttererFase 3
- Curtis and Elizabeth Anderson Cancer, Savannah
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruttererObservasjonsstudie
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi unna
- The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island · 22 mi unna
- og 1 flere
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Savannah
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Savannah
- Brystkreft11 studier
- Lungekreft10 studier
- Kreft (alle typer)6 studier
- Major depresjon6 studier
- Type 2-diabetes6 studier
- Melanom5 studier
- KOLS5 studier
- Eggstokkreft4 studier
- Kolorektal kreft4 studier
- Non-Hodgkins lymfom3 studier
- Mani3 studier
- Akut myelogen leukemi3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.